• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.人类结肠癌的蛋白质基因组分析揭示了新的治疗机会。
Cell. 2019 May 2;177(4):1035-1049.e19. doi: 10.1016/j.cell.2019.03.030. Epub 2019 Apr 25.
2
Analysis of the transcriptomic features of microsatellite instability subtype colon cancer.分析微卫星不稳定亚型结肠癌的转录组特征。
BMC Cancer. 2019 Jun 20;19(1):605. doi: 10.1186/s12885-019-5802-2.
3
Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection.通过激光显微切割富集肿瘤细胞对治疗困难的乳腺癌进行蛋白质基因组学特征分析。
Breast Cancer Res. 2024 May 14;26(1):76. doi: 10.1186/s13058-024-01835-4.
4
Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles.右半结肠癌、左半结肠癌和直肠癌的比较蛋白质基因组分析揭示了不同的突变特征。
Mol Cancer. 2018 Dec 21;17(1):177. doi: 10.1186/s12943-018-0923-9.
5
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.基于基因组与蛋白质组联合分析的肺腺癌治疗靶点研究
Cell. 2020 Jul 9;182(1):200-225.e35. doi: 10.1016/j.cell.2020.06.013.
6
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.乳腺癌发生和靶向治疗的蛋白质基因组全景分析
Cell. 2020 Nov 25;183(5):1436-1456.e31. doi: 10.1016/j.cell.2020.10.036. Epub 2020 Nov 18.
7
A proteogenomics data-driven knowledge base of human cancer.一个基于人类癌症的蛋白质基因组学数据驱动的知识库。
Cell Syst. 2023 Sep 20;14(9):777-787.e5. doi: 10.1016/j.cels.2023.07.007. Epub 2023 Aug 23.
8
Proteogenomics for understanding oncology: recent advances and future prospects.用于肿瘤学研究的蛋白质基因组学:最新进展与未来展望
Expert Rev Proteomics. 2016;13(3):297-308. doi: 10.1586/14789450.2016.1136217. Epub 2016 Jan 25.
9
Pan-cancer proteogenomics expands the landscape of therapeutic targets.泛癌种蛋白质基因组学拓展了治疗靶点图谱。
Cell. 2024 Aug 8;187(16):4389-4407.e15. doi: 10.1016/j.cell.2024.05.039. Epub 2024 Jun 24.
10
Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.癌症耐药性的蛋白质基因组学研究:迈向生物标志物发现与靶点鉴定
Expert Rev Proteomics. 2017 Apr;14(4):351-362. doi: 10.1080/14789450.2017.1299006. Epub 2017 Mar 6.

引用本文的文献

1
Comprehensive proteomic characterization of pulmonary arterial hypertension in Chinese people.中国人肺动脉高压的综合蛋白质组学特征分析
Front Mol Biosci. 2025 Aug 14;12:1652083. doi: 10.3389/fmolb.2025.1652083. eCollection 2025.
2
Integrative proteogenomic characterization of Wilms tumor.肾母细胞瘤的综合蛋白质基因组特征分析
Nat Commun. 2025 Aug 19;16(1):7715. doi: 10.1038/s41467-025-62234-7.
3
Proteogenomic characterization of invasive breast tumors in young women.年轻女性浸润性乳腺癌的蛋白质基因组特征分析
NPJ Breast Cancer. 2025 Aug 18;11(1):94. doi: 10.1038/s41523-025-00793-0.
4
TRIM31 triggers colorectal carcinogenesis and progression by maintaining YBX1 protein stability through ubiquitination modification.TRIM31通过泛素化修饰维持YBX1蛋白稳定性,从而引发结直肠癌的发生和进展。
Cell Death Dis. 2025 Aug 16;16(1):621. doi: 10.1038/s41419-025-07922-4.
5
Integrated cytomembrane proteomics identifies EpCAM/MGST1 as therapeutic targets in metastatic laryngeal carcinoma.整合细胞膜蛋白质组学鉴定EpCAM/MGST1为转移性喉癌的治疗靶点。
Front Genet. 2025 Jul 24;16:1615570. doi: 10.3389/fgene.2025.1615570. eCollection 2025.
6
Discovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activity.氮杂胞苷和地西他滨抗癌活性的基于染色质的决定因素的发现。
bioRxiv. 2025 Aug 1:2025.07.29.664810. doi: 10.1101/2025.07.29.664810.
7
Proteogenomic Insights Into Glioblastoma Evolution: Neuronal Reprogramming and Therapeutic Vulnerabilities.胶质母细胞瘤进化的蛋白质基因组学见解:神经元重编程与治疗脆弱性
Brain Tumor Res Treat. 2025 Jul;13(3):81-86. doi: 10.14791/btrt.2025.0018.
8
AUTO-SP: Automated Sample Preparation for Analyzing Proteins and Protein Modifications.AUTO-SP:用于分析蛋白质和蛋白质修饰的自动化样品制备
Anal Chem. 2025 Aug 12;97(31):16751-16758. doi: 10.1021/acs.analchem.5c00886. Epub 2025 Jul 28.
9
Integrative multi-omics characterization of 12 syngeneic mouse models.12种同基因小鼠模型的整合多组学特征分析
iScience. 2025 Jun 27;28(8):113024. doi: 10.1016/j.isci.2025.113024. eCollection 2025 Aug 15.
10
WD40 Protein NLE1 as a Novel Diagnostic Biomarker Promoting Hepatocellular Carcinoma Proliferation.WD40蛋白NLE1作为一种促进肝细胞癌增殖的新型诊断生物标志物。
Clin Med Insights Oncol. 2025 Jul 1;19:11795549251348902. doi: 10.1177/11795549251348902. eCollection 2025.

本文引用的文献

1
PepQuery enables fast, accurate, and convenient proteomic validation of novel genomic alterations.PepQuery 可实现对新型基因组改变的快速、准确和便捷的蛋白质组学验证。
Genome Res. 2019 Mar;29(3):485-493. doi: 10.1101/gr.235028.118. Epub 2019 Jan 4.
2
Immune Evasion in Tumor's Own Sweet Way.肿瘤的“甜蜜”免疫逃逸
Cell Metab. 2018 May 1;27(5):945-946. doi: 10.1016/j.cmet.2018.03.013. Epub 2018 Apr 5.
3
LinkedOmics: analyzing multi-omics data within and across 32 cancer types.LinkedOmics:在 32 种癌症类型内和类型间分析多组学数据。
Nucleic Acids Res. 2018 Jan 4;46(D1):D956-D963. doi: 10.1093/nar/gkx1090.
4
NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data.NetMHCpan-4.0:整合洗脱配体和肽结合亲和力数据的改进的肽与主要组织相容性复合体I类相互作用预测
J Immunol. 2017 Nov 1;199(9):3360-3368. doi: 10.4049/jimmunol.1700893. Epub 2017 Oct 4.
5
Analysis of somatic microsatellite indels identifies driver events in human tumors.体细胞微卫星插入缺失分析可识别人类肿瘤中的驱动事件。
Nat Biotechnol. 2017 Oct;35(10):951-959. doi: 10.1038/nbt.3966. Epub 2017 Sep 11.
6
A pathology atlas of the human cancer transcriptome.人类癌症转录组病理学图谱。
Science. 2017 Aug 18;357(6352). doi: 10.1126/science.aan2507.
7
SIGNOR: A Database of Causal Relationships Between Biological Entities-A Short Guide to Searching and Browsing.SIGNOR:生物实体之间因果关系的数据库——搜索与浏览简短指南。
Curr Protoc Bioinformatics. 2017 Jun 27;58:8.23.1-8.23.16. doi: 10.1002/cpbi.28.
8
Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.结直肠癌细胞系蛋白质组可代表原发性肿瘤并预测药物敏感性。
Gastroenterology. 2017 Oct;153(4):1082-1095. doi: 10.1053/j.gastro.2017.06.008. Epub 2017 Jun 16.
9
WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit.WebGestalt 2017:一个更全面、强大、灵活和互动的基因集富集分析工具包。
Nucleic Acids Res. 2017 Jul 3;45(W1):W130-W137. doi: 10.1093/nar/gkx356.
10
metaX: a flexible and comprehensive software for processing metabolomics data.MetaX:一款用于处理代谢组学数据的灵活且全面的软件。
BMC Bioinformatics. 2017 Mar 21;18(1):183. doi: 10.1186/s12859-017-1579-y.

人类结肠癌的蛋白质基因组分析揭示了新的治疗机会。

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.

机构信息

Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.

出版信息

Cell. 2019 May 2;177(4):1035-1049.e19. doi: 10.1016/j.cell.2019.03.030. Epub 2019 Apr 25.

DOI:10.1016/j.cell.2019.03.030
PMID:31031003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6768830/
Abstract

We performed the first proteogenomic study on a prospectively collected colon cancer cohort. Comparative proteomic and phosphoproteomic analysis of paired tumor and normal adjacent tissues produced a catalog of colon cancer-associated proteins and phosphosites, including known and putative new biomarkers, drug targets, and cancer/testis antigens. Proteogenomic integration not only prioritized genomically inferred targets, such as copy-number drivers and mutation-derived neoantigens, but also yielded novel findings. Phosphoproteomics data associated Rb phosphorylation with increased proliferation and decreased apoptosis in colon cancer, which explains why this classical tumor suppressor is amplified in colon tumors and suggests a rationale for targeting Rb phosphorylation in colon cancer. Proteomics identified an association between decreased CD8 T cell infiltration and increased glycolysis in microsatellite instability-high (MSI-H) tumors, suggesting glycolysis as a potential target to overcome the resistance of MSI-H tumors to immune checkpoint blockade. Proteogenomics presents new avenues for biological discoveries and therapeutic development.

摘要

我们对一个前瞻性收集的结肠癌队列进行了首次蛋白质基因组学研究。对配对的肿瘤和正常相邻组织进行比较蛋白质组学和磷酸化蛋白质组学分析,产生了一个与结肠癌相关的蛋白质和磷酸化位点目录,包括已知和推测的新生物标志物、药物靶点和癌症/睾丸抗原。蛋白质基因组学整合不仅优先考虑了基因组推断的靶标,如拷贝数驱动和突变衍生的新抗原,还产生了新的发现。磷酸化蛋白质组学数据将 Rb 磷酸化与结肠癌中增殖增加和凋亡减少相关联,这解释了为什么这个经典的肿瘤抑制因子在结肠癌中扩增,并为在结肠癌中靶向 Rb 磷酸化提供了依据。蛋白质组学鉴定出微卫星不稳定性高(MSI-H)肿瘤中 CD8 T 细胞浸润减少和糖酵解增加之间的关联,表明糖酵解可能是克服 MSI-H 肿瘤对免疫检查点阻断的耐药性的潜在靶点。蛋白质基因组学为生物学发现和治疗开发提供了新的途径。